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Impaired potassium-induced insulin secretion in chronic renal failure.
Extrarenal disposal of potassium load is impaired in chronic renal
failure (CRF). This has been attributed to excess PTH since extrarenal
disposition of potassium is normal in CRF-PTX animals. Insulin aug-
ments potassium entry into cells and hyperkalemia stimulates insulin
secretion. Since glucose-induced insulin secretion is impaired in CRF
and normal in CRF-PTX, it is possible that K-induced insulin secre-
tion is also impaired in CRF due to excess PTH. Such a defect would
contribute to the abnormality in extrarenal disposal of potassium in
CRF. We examined K-induced insulin secretion, cytosolic calcium
([Ca21i) and the changes in [Ca2]i in response to 20 ms'i KCI of islets
from normal, CRF, and CRF-PTX rats; and normal and CRF animals
treated with verapamil (normal-V and CRF-V). K-induced insulin
secretion by islets isolated from CRF rats was significantly (P < 0.01)
lower than that from normal, CRF-PTX, CRF-V and normal-V rats.
Basal level of [Ca2Ii in islets of CRF rats was significantly (P < 0.01)
higher than in islets of the other four groups of animals. The calcium
signal ( (Ca21i) and the [Ca24ii/basal [Ca2'ii ratio in response to 20
mM KCI observed in islets from CRF rats were significantly lower than
in the other four groups of animals. The data indicate that: I) K-
induced insulin secretion in islets of CRF is impaired, most likely, due
to elevated basal level of [Ca2Ii and reduced calcium signal and/or
smaller [Ca2]i/basal [Ca241i ratio in response to KCI; 2) the defect in
K-induced insulin secretion may contribute to the impaired extrarenal
potassium disposal in CRF; and 3) the abnormalities in pancreatic islets
may be mediated by the chronic excess of PTH in CRF.
Several studies have demonstrated that extrarenal disposal of
a potassium load is impaired in both acute [1—3] and chronic
renal failure (CRF) [4, 5]. Both aldosterone and epinephrine
regulate extrarenal disposal of potassium [6], and a defect in
these hormones in CRF could contribute to the abnormality in
the reduced extrarenal disposal of this ion. However, aldoste-
rone production is not reduced [7] and blood levels of catechol-
amines are elevated [8] in CRF.
Both acute [9] and chronic renal failure [10—12] are associated
with secondary hyperparathyroidism and elevated blood levels
of parathyroid hormone (PTH). This hormone enhances entry
of calcium into cells [13—17] and chronic excess of PTH with or
without CRF is associated with a rise in the basal levels of
cytosolic calcium ([Ca2ii) in many cells [12, 18—20]. Since the
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permeability of cellular membrane to potassium is affected by
cytosolic calcium ([Ca2]i) [21—23], it is possible that excess
PTH by inducing a rise in [Ca2]i is a major factor underlying
the impairment in extrarenal disposal of potassium in CRF.
Indeed the studies of Sugarman and Kahn [2, 3] and ours [5]
support this proposition in that prevention of secondary hyper-
parathyroidism in CRF by parathyroidectomy (PTX) or block-
age of the excessive PTH-induced entry of calcium into cells by
a calcium channel blocker corrected the abnormality in extra-
renal potassium handling [5].
However, excess PTH in CRF may interfere with extrarenal
disposal of a potassium load through another pathway. Potas-
sium stimulates insulin release from the pancreas [24] and many
studies have demonstrated that insulin is an important regulator
of extrarenal disposition of potassium [61. Since secondary
hyperparathyroidism of CRF impairs glucose-induced insulin
secretion [12, 18, 25], it is possible that it also interferes with
potassium-induced insulin secretion which would contribute to
the overall process underlying the derangement of extrarenal
potassium handling in CRF. The present study was designed to
examine the effect of CRF with and without excess PTH on
potassium-induced insulin secretion by pancreatic islets.
Methods
Male Sprague-Dawley rats weighing 170—250 g were studied.
They were fed normal rat chow diet (ICN Nutritional Biochem-
ical, Cleveland, Ohio, USA) throughout the study and were
allowed to drink ad libitum. Experiments were performed in
five groups of animals: a) normal rats, b) rats with CRF of 42
days duration, c) CRF-PTX rats maintained normocalcemic d)
CRF rats treated with verapamil (0.1 .tgIg body wt) given
subcutaneously twice a day from day one of CRF (CRF-V), e)
normal rats treated with verapamil for 42 days (normal-V). CRF
was produced by 5/6 nephrectomy; the animals underwent right
2/3 nephrectomy through a flank incision and a week later, a left
nephrectomy was performed. PTX was performed by electro-
cautery, and the success of the procedure was ascertained by a
decrease in serum levels of calcium of at least 2 mg/dl. The PTX
rats were allowed to drink water containing 5% calcium glu-
conate; this procedure is adequate to normalize serum calcium
in the PTX rats. Seven days after PTX, the rats were subjected
to 5/6 nephrectomy. Two days before the sacrifice of the
animals, they were housed in metabolic cages to obtain two
consecutive, 24-hour urine collections for the measurement of
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creatinine clearance. The night before each study, the rats were
fasted for 16 hours. The animals were sacrificed by decapitation
after 42 days following completion of the 5/6 nephrectomy in
CRF rats (CRF, CRF-PTX, CRF-VER) and after 42 days of
verapamil treatment of normal rats. The pancreas was re-
moved, dissected free of adipose tissue and lymph nodes. The
islets of Langerhans were isolated by the collagenase digestion
method [26] and picked under a dissecting microscope.
Potassium-induced insulin secretion was examined by dy-
namic perifusion studies of pancreatic islets. The details of this
technique have been reported previously from our laboratory
[25]. Twenty size-matched islets were used in each study. First,
the islets were perifused with Krebs-Ringer bicarbonate buffer
(pH 7.4) containing 2.8 m glucose and 3.5 mr..i KCI for 30
minutes. Thereafter, the potassium concentration was in-
creased to 20 mrvi and the perifusion was continued for addi-
tional 30 minutes. Effluent was collected for six minutes prior to
the change in potassium concentration and for 30 minutes
thereafter for a total of 21 collections. Insulin secretion began to
increase two minutes after the change of potassium concentra-
tion. Therefore, the average value of insulin release during the
six minutes prior to the change in potassium concentration and
the two minutes immediately thereafter were used as baseline
level. The changes in insulin secretion from baseline with time
were examined by calculating area under the curve for each
study. This calculation allowed us to estimate insulin release
during the initial phase (8 mm including 3rd through 10th
minutes) which is known to increase in response to potassium.
It should be mentioned that the concentrations of potassium
(20 mEq/liter) used in the perifusate of the pancreatic islets
were high and did not correspond with potential changes of
potassium in vivo. However, the choice of 20 mEq/liter of
potassium was made since lower concentrations of potassium
elicit small changes in insulin secretion. Gomez and Curry [24]
found that increasing potassium concentration to 8, 12 mEq/
liter produced very little change in insulin secretion. We also
found in preliminary studies of static incubations [25] that
increasing potassium concentration to 8, 12, and 20 mEq/liter
produced an increase in insulin secretion of 5.3 2.6, 8.1 3.1,
and 15.0 3.7, pg/islet/mm, respectively.
Cytosolic calcium of the pancreatic islets was measured with
fura 2/AM (Sigma Chemical Co., St. Louis, Missouri, USA) as
described by Komatsu et al [271. This technique utilizes entire
islets and not dispersed islets cells as we have reported previ-
ously [12]. One hundred and fifty islets, isolated from the
pancreas of one rat, were loaded with fura 2/AM by incubation
in 2 M of fura 2/AM for 30 minutes in an incubation medium
containing the following in mM: 128 NaCI, 3.5 KCI, 1 MgCI2, 1.2
KH2PO4, 1.0 CaC12, 1.25 NaHCO3, 20 HEPES, 2.8 glucose and
5 mg/mI BSA (pH 7.4). To remove the unincorporated probe,
the islets were centrifuged for three to five seconds in an
Eppendorf microfuge and washed twice and finally suspended
in 2 ml of the incubation media. Measurement of fluorescence
was done with Perkin-Elmer fluorescence spectrophotometer
model LS-5B (Perkin-Elmer, Norwalk, Connecticut, USA) at
excitation wavelength of 340 nm and emission wavelength of
510 nm. Komatsu et al found that the fluorescence signal of the
preparation of the islet remains stable for at least a period of 25
minutes at excitation wavelength of 340 nm and emission
wavelength of 510 nm. We also examined this issue in our
studies and found the fluorescence signal of our preparation to
be stable for at least 30 minutes, indicating that no leak of dye
occurred over this period of time. After recording a steady
state, 10 d of 3.4 M KCI stock was added to the 2 ml islet
suspension to raise the KCI concentration to 20 m and the
fluorescence was recorded for 20 minutes. Maximal floures-
cence (Fmax) and minimal fluorescence (Fmj) were estimated as
previously reported [19]. The islets were lysed by 0.07% triton
X-100 to obtain the Fmax; subsequently 5 mi''i EGTA (pH 13.2)
was added to obtain the Fmjn. Islets were washed before each
experiment and the above-mentioned calibration for fura 2
signal was performed after each experiment, To eliminate the
effect of autofluorescence due to cuvette, medium and unloaded
islets, autofluorescence was measured before each experiment
and was accounted for by setting the fluorometer to autozero
before each measurement. Calculation of cytosolic calcium was
made utilizing the Grynkiewicz equation: [Ca]i=Kd (FFmtn)/
(FmaxF) [27, 28]. The dissociation constant (Kd) for Ca2-Fura
2 was assumed to be 225 flM. Both basal [Ca2]i and the effect
of 20 mi KCI on [Ca2]i were evaluated.
The measurements of calcium and magnesium concentration
in plasma were made by Perkin-Elmer atomic absorption spec-
trophotometer, Model 503 and those of creatinine and phospho-
rus by Technicon autoanalyzer (Technicon Instrument Inc.,
Tarrytown, New York, USA). Plasma potassium was measured
with IL flame photometer (Instrumentation Laboratory, Water-
town, Massachusetts, USA). Insulin was determined by char-
coal-coated radioimmunoassay using rat insulin as standard
[29]. Serum level of PTH was determined by INS-PTH immu-
noassay kit (Nichols Institute Diagnostics, San Juan, Capist-
rano, California, USA). This assay recognizes the aminotermi-
nal fragment of PTH. The lowest detectable level is 3 pg/mI, the
interassay variation is 7.3% and intraassay variation is 4%.
Statistical analysis was done with the Clinfo computer sys-
tem. The data are presented as mean SE. Changes in parameters
with multiple measurements with time were evaluated by cal-
culating the area under the curve for each experiment utilizing
the trapezoidal rule. The significance of the differences in the
data of the various groups was made by one-way analysis of
variance and Duncan multiple range test.
Results
The biochemical data in the five groups of animals studied are
given in Table 1. The 5/6 nephrectomy was associated with
significant (P < 0.01) elevation in the concentration of creati-
nine in plasma with the values being three to four times higher
than normal. There were significant (P < 0.01) reductions in
creatinine clearance in CRF, CRF-PTX and CRF-V rats as
compared to values in normal and normal-V rats. The values of
creatinine clearance in CRF, CRF-PTX and CRF-V rats were
not different. The plasma concentrations of calcium and phos-
phorus in the five groups were not different. Plasma potassium
in CRF rats was significantly (P < 0.01) higher than all other
groups and it was normal in CRF-PTX and CRF-V rats; these
observations were similar to those previously reported from our
laboratory [5]. The serum levels of PTH in CRF and CRF-V rats
were significantly (P < 0.01) higher than those in normal,
normal-V and CRF-PTX rats, and the values in the latter
animals were significantly (P < 0.01) lower than those in the
other groups.
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Table 1. Biochemical variables in the five groups of rats at the time of sacrifice
Weight
g
Creatinine
Plasma
Calcium
mg/dI
Normal 212 6 0.41 ÷ 0.02 9.4 0.2
CRF 178 6 1.50 0.22" 9.5 0.5
CRF-PTX 210 13 1.32 0.20" 9.6 0.4
Normal-V 208 13 0.43 0.03 9.3 0.3
CRF-V 188 7 1.36 + 0.20"
vs. normal and normal-VER
8.7 0.5
a P < 0.01
b P < 0.01 vs. all other groups
Creatinine
clearance
pJ/min/100 g
828 69
233 18"
220 27'
690 46
292 54"
80
70
60
50
'a
43
0.
30
20
10
0
Plasma Serum
Phosphorus potassium PTH
__________
mEqlliter pg/mi
8.1 ÷ 0.2 4.20 0.10 18 1.6
8.1 0.4 5.20 ÷ 010b 51 6.8'
8.9 0.5 4.15 0.15 10
8.1 0.5 4.25 0.10 21 0.6
7.7 0.6 4.10 0.18 72 17.7"
80
70
60
50
40
0.
30•C
20
10
0• — ______
—10
—10 —5 0 5 10 15 20 25 30
Time, minutes
Fig. 1. Dynamic studies of potassium-induced insulin release from
perifused pancreatic islets of 6 normal (0), 5 CRF(A) and6 CRF-PTX
(A) rats. The glucose concentration of the perifusate was 2.8 ms
throughout the study, and at time 0 the concentration of potassium was
increased to 20 mM. Each datum point represents the mean value and
the brackets depict I SE. The area under the curve of the initial phase of
insulin release (minutes 3 to 10, 8 minutes) in CRF rats is significantly
smaller than those in normal or CRF-PTX rats.
Potassium-induced insulin secretion during dynamic perifu-
sion studies of islets from normal, CRF and CRF-PTX rats is
shown in Figure 1. Early insulin release (8 mm) calculated from
area under the curve in CRF rats (57 10.2 pg/islet 8 mm) was
significantly (P < 0.01) lower than in normal (200 36.4
pg/islet 8 mm) or CRF-PTX (189 31.2 pg/islet 8 mm) rats.
The values between normal and CRF-PTX rats were not
different. Treatment of CRF rats with verapamil corrected the
abnormality in insulin secretion by pancreatic islets isolated
from these rats (Fig. 2). The area under the curve in CRF-V rats
(185 22.5 pg/islet 8 mm) was significantly (P < 0.01) higher
than that in CRF rats and not different from those in normal and
CRF-PTX rats. Verapamil treatment of normal rats did not
affect insulin secretion by islets isolated from these rats with
area under the curve, being 200 40.6 pg/islet 8 mm.
Figure 3 depicts the basal levels of cytosolic calcium in the
various groups studied, and Table 2 provides the change in
[Ca2 Ii and ratio between the [Ca2Ji/basal [Ca2 ]i in re-
sponse to 20 mtvi KC1 in the five group of animals. The values of
basal [Ca2Ii in islets of normal rats (89 3.4 nM) were not
different from those (72 10.1 nM) reported by Komatsu et al
[271. The basal levels of [Ca2'ii in islets of CRF rats were
significantly (P < 0.01) higher than those in the islets of the
I I I
—5 0 5 10 15
Time, minutes
Fig. 2. Dynamic 2tudies of potassium-induced insulin release from
perifused pancreatic islets of 5 CRF (shaded area), 5 CRF-V (U) and 6
normal-V (LI) rats. Each datum point represents mean value and
brackets denote I SE. Shaded area represent the mean 1 SE. The
values of the area under the curve of the initial phase of insulin release
(minutes 3 to 10, 8 minutes) in normal-V and CRF-V rats are signifi-
cantly higher than that in CRF rats and are not different from those in
normal or CRF-PTX rats.
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Fig. 3. Basal levels of [Ca2 Ii in the five groups of animals studied.
Each datum point represents one animal. Brackets denote mean I SE.
The values in CRF animals were significantly higher than the other 4
groups of rats.
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Table 2. Effect of 20 msi KCI on [Ca2]i of the islets isolated from the various groups of rats
N
Basal [Ca2 ii [Ca2}i after 20 msi KCI [Ca2 +
Basal [Ca2 ]j rationM
Normal 6 89 3.4 120 14.4 1.35 0.14
CRF 8 133 44a SI Io.Ia 0.40 0.08k
CRF-PTX 6 94 2,6 155 13.5 1.65 0.16
Normal-V 6 82 5.1 82 5,71 1.00 008b
CRF-V 6 88 3.7 82 136b 0.91 0.12'
a P < 0.01 vs. all other groups
b P < 0.01 vs. CRF-PTX
other four groups of animals. The [Ca2ii and the [Ca2]iI
basal [Ca2]i ratio in islets from CRF rats in response to 20 mM
KCI were significantly (P < 0.01) lower than in the other four
groups of animals. Although the i.\ [Ca211i/basal [Ca2]i ratio in
the islets from normal-V and CRF-V rats were not different
from those in islets of normal rats, they were lower than values
in islets from CRF-PTX rats.
Discussion
Our data, as those of others [24], show that potassium
stimulates the initial phase of insulin secretion from islets
isolated from normal rats, and further demonstrate that the
potassium-induced insulin secretion is significantly (P < 0.01)
reduced in islets isolated from CRF rats. This derangement is
prevented by prior PTX of the CRF rats or by their treatment
with the calcium channel blocker, verapamil.
Potassium-induced insulin secretion is mediated by a rise in
[Ca2]i [30—32]. Potassium depolarizes the islet membrane and
allows calcium to enter the islet, resulting in an acute rise in
[Ca2]i, which in turn triggers cellular events that leads to
insulin secretion [32]. It has been suggested that an appropriate
response of cells to agonists requires adequate calcium signal (
[Ca2]i) and/or [Ca2]i/basal [Ca24]i ratio [331. Therefore, a
smaller X [Ca2]i and/or [Ca2]i/basal [Ca2ii ratio could be
associated with impaired insulin secretion. Our data show that
both the i [Ca2]i and the [Ca2]i/basal [Ca2]i ratio in islets
of CRF rats and their insulin secretion in response to KCI are
significantly lower than in the other four groups. Our observa-
tions are, therefore, consistent with the proposition that CRF
with excess PTH causes a sustained elevation in basal [Ca211i,
and the latter is associated with a reduced calcium signal and a
smaller [Ca2ii/basal [Ca2]i ratio in response to KCI, and
hence reduced insulin secretion. PTX of the CRF rats or their
treatment with verapamil, by preventing the chronic persistent
rise in basal [Ca2 ]i, allows an adequate calcium signal and high
[Ca211i/basal [Ca2Ji ratio and hence normal insulin secre-
tion. A corollary to our studies in pancreatic islets is found in
observation in human polymorphonuclear leucocytes (PMNL)
from dialysis patients and high blood levels of PTH [19]. The
PMNL in these patients had elevated basal levels of [Ca2]i and
displayed smaller calcium signal and i [Ca2]i/basal [Ca2Ji
ratio and reduced physiological response to the ligation of their
Fc y Ru! receptors to 3G8 monoclonal antibody.
The mechanisms responsible for the elevation in basal levels
of [Ca2]i in islets of CRF rats are complex and have been
previously defined by us [12]. They involved augmented cal-
cium entry, inhibition of mitochondrial oxygen consumption,
reduced ATP content, and impaired calcium extrusion second-
ary to reduced activity of Ca2 ATPase [12].
The demonstration that potassium-induced insulin secretion
is reduced in CRF indicate that this defect in insulin secretion
contributes, at least partly, to the impaired extrarenal disposal
of a potassium load in CRF. These data provide another
pathway through which excess PTH in CRF may participate in
the reduced extrarenal disposition of potassium.
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